相关实验视频
Updated: Jan 6, 2026

05:16
Sleeve Gastrectomy in Mice using Surgical Clips
Published on: November 14, 2020
7.2K
代谢手术治疗肥胖型2型糖尿病:韩国多中心队列研究
Young Suk Park1, Soo Min Ahn2, Sang Hyun Kim3
1Department of Surgery, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Seoul, Korea, Republic of.
Obesity surgery
|November 13, 2025
概括
袖子胃切除术 (SG) 和Roux-en-Y胃绕道术 (RYGB) 在1-2年后对韩国成年人2型糖尿病 (T2DM) 缓解没有显著差异. 需要进一步的研究来证实这些发现.
科学领域:
- 代谢手术是一种代谢手术.
- 减肥手术 减肥手术的方法
- 2型糖尿病 (T2DM) 的管理
背景情况:
- 代谢/腹腔外科手术有效治疗肥胖和T2DM.
- 袖子胃切除术 (SG) 和Roux-en-Y胃绕道术 (RYGB) 是常见的手术.
- 对于东亚人口的比较数据有限.
研究的目的:
- 为了比较SG和RYGB的代谢益处.
- 评估韩国成年人T2DM缓解率.
- 为了评估手术后1年和2年的外科结果.
主要方法:
- 多中心回顾性队列研究.
- 韩国成年人 (BMI ≥30 kg/m2) 患有T2DM经历SG或RYGB.
- 主要结局:在1年和2年完全缓解T2DM.
- 治疗权重的逆概率 (IPTW) 进行调整.
主要成果:
- 未经调整的分析有利于在1年和2年后T2DM缓解的SG.
- 调整后的分析 (IPTW) 显示SG和RYGB之间没有显著差异.
- 较短的T2DM持续时间和不使用胰岛素预测了缓解,而不是手术类型.
结论:
- 在韩国患者中,SG和RYGB之间的T2DM缓解没有统计学上显著的差异.
- 由于样本大小和随访时间,研究结果需要谨慎解释.
- 为了验证临床决策,需要进行前性研究.
相关概念视频
Obesity
1.1K
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.1K
Carbohydrate Metabolism
13.7K
Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
13.7K
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
211
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
211
Diabetes Mellitus: Type 2 and Gestational
4.2K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
4.2K
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
149
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
149
Drug Dosing: Obese Patients
189
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
189

